Serum eosinophil cationic protein (S-ECP) in a population with low prevalence of atopy

AbstractThe study is a part of the European Community Respiratory Health Survey. A random sample (n=351) of 20–44-year olds and persons of the same age with asthma-like symptoms or current asthma medication according to a postal questionnaire (n=95) were studied. Interview was taken, methacholine challenge was done and ECP, total and specific IgE were measured from serum. The median S-ECP value was 8.0 μg/l in the random sample. The geometric mean of S-ECP was higher in subjects with, than without atopy (10.2. vs 8.9 μg/l, P<0.01) and in subjects with bronchial hyperresponsiveness (BHR) than in subjects without BHR (9.9 vs 8.0 μg/l,P <0.01). The levels correlated weakly to forced expiratory volume in one second (FEV1) (r=0.13, P<0.01) and were not independently correlated with respiratory symptoms, asthma or FEV1 after adjusting for BHR, IgE, sensitisation and smoking. Our results indicate that the level of eosinophil activation is low in a population with a low prevalence of atopy, even when BHR is common

LIBS applicability for investigation of re-deposition and fuel retention in tungsten coatings exposed to pure and nitrogen-mixed deuterium plasmas of Magnum-PSI

We have investigated the applicability of Laser Induced Breakdown Spectroscopy (LIBS) for analyzing the changes in the composition and fuel retention of W and W-Ta coatings following exposure to D2 or mixed D2-N2 plasma beams in the linear plasma device Magnum PSI. The exposed samples were characterized by in situ ns-LIBS and complementary analysis methods Secondary Ion Mass Spectroscopy, Energy Dispersive x-ray spectroscopy and Nuclear Reaction Analysis. In agreement with the used complementary analysis methods, LIBS revealed the formation of up to 400 nm thick co-deposited surface layer in the central region of the coatings which contained a higher concentration of the main plasma impurities, such as N, and metals, such as Ta and Mo, the latter originating mainly from the substrate and from the plasma source. The deuterium retention on the other hand was highest outside from the central region of the coatings.</p

Changes in the use of anti-asthmatic medication in an international cohort

To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldThe aim of this study was to describe changes in pharmacotherapy for asthma since the early 1990s in an international cohort of young and middle-aged adults. A total of 28 centres from 14 countries participated in a longitudinal study. The study included 8,829 subjects with a mean follow-up time of 8.7 yrs. Change in the prevalence of use for medication was expressed as absolute net change (95% confidence interval) standardised to a 10-yr period. The use of anti-asthmatics was found to have increased by 3.1% (2.4-3.7%) and the prevalence of symptomatic asthma by 4.0% (3.5-4.5%). In the sample with asthma in both surveys (n=423), the use of inhaled corticosteroids increased by 12.2% (6.6-17.8%). Despite this, only 17.2% were using inhaled corticosteroids on a daily basis at follow-up. Females with continuous asthma were more likely, compared with males, and smokers with asthma, to have started using inhaled corticosteroids since the first survey. The use of anti-asthmatics has increased in a pattern consistent with current consensus on treatment. However, despite increased use of inhaled corticosteroids, a large majority of subjects with symptomatic asthma do not use this treatment on a daily basis, particularly males and smokers with asthma

Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms

Several studies have identified obesity as a risk factor for asthma in both children and adults. An increased prevalence of asthma in subjects with gastro-oesophageal reflux (GOR) and obstructive sleep apnoea syndrome has also been reported. The aim of this investigation was to study obesity, nocturnal GOR and snoring as independent risk factors for onset of asthma and respiratory symptoms in a Nordic population. In a 5-10 yr follow-up study of the European Community Respiratory Health Survey in Iceland, Norway, Denmark, Sweden and Estonia, a postal questionnaire was sent to previous respondents. A total of 16,191 participants responded to the questionnaire. Reported onset of asthma, wheeze and night-time symptoms as well as nocturnal GOR and habitual snoring increased in prevalence along with the increase in body mass index (BMI). After adjusting for nocturnal GOR, habitual snoring and other confounders, obesity (BMI >30) remained significantly related to the onset of asthma, wheeze and night-time symptoms. Nocturnal GOR was independently related to the onset of asthma and in addition, both nocturnal GOR and habitual snoring were independently related to onset of wheeze and night-time symptoms. This study adds evidence to an independent relationship between obesity, nocturnal gastro-oesophageal reflux and habitual snoring and the onset of asthma and respiratory symptoms in adults

Cohort Profile: Burden of Obstructive Lung Disease (BOLD) study

The Burden of Obstructive Lung Disease (BOLD) study was established to assess the prevalence of chronic airflow obstruction, a key characteristic of chronic obstructive pulmonary disease, and its risk factors in adults (≥40 years) from general populations across the world. The baseline study was conducted between 2003 and 2016, in 41 sites across Africa, Asia, Europe, North America, the Caribbean and Oceania, and collected high-quality pre- and post-bronchodilator spirometry from 28 828 participants. The follow-up study was conducted between 2019 and 2021, in 18 sites across Africa, Asia, Europe and the Caribbean. At baseline, there were in these sites 12 502 participants with high-quality spirometry. A total of 6452 were followed up, with 5936 completing the study core questionnaire. Of these, 4044 also provided high-quality pre- and post-bronchodilator spirometry. On both occasions, the core questionnaire covered information on respiratory symptoms, doctor diagnoses, health care use, medication use and ealth status, as well as potential risk factors. Information on occupation, environmental exposures and diet was also collected

The prevalence of chronic airflow obstruction in three cities in the Nordic-Baltic region

Background: Chronic airflow obstruction (CAO) is the primary characteristic of Chronic obstructive pulmonary disease (COPD) but is also seen in chronic asthma. Objective: To compare the prevalence of CAO and possible risk factors between Tartu in Estonia, Reykjavik in Iceland and Uppsala in Sweden. Methods: All participants underwent spirometry testing of forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) before and after bronchodilation. CAO was defined as post-bronchodilator FEV1/FVC below lower limit of normal. Information on respiratory diseases and smoking status, was obtained through questionnaires administered by trained interviewers. Results: 1037 men and 956 women participated in the study. The prevalence of CAO was lower in women in Tartu compared to the other centres (4.9% vs. 13.4 and 8.7% in Reykjavik and Uppsala, respectively, p = 0.002) while no difference was found for men. A similar picture was seen for the proportion of participants that had smoked 10 pack years or more which was much lower in Tartu for women than in Reykjavik and Uppsala, respectively (13.2% vs. 33.7 and 29.2%, p < 0.001). (Fig. 1). Of the participants with CAO the majority (57–67%) did not have a previous diagnosis of asthma or COPD. Conclusion: The prevalence of CAO was lower in Estonian women than in women from Iceland and Sweden. The reason for this was probably that the Estonian women had smoked less than the female participants from Iceland and Sweden. The majority of those with CAO do not have a diagnosed lung disease

Comparison of LIBS results on ITER-relevant samples obtained by nanosecond and picosecond lasers

This work has been carried out within the framework of the EUROfusion Consortium and has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement number 633053. The views and opinions expressed herein do not necessarily reflect those of the European Commission. Work performed under EUROfusion WP PFC.ITER foresees applying laser induced breakdown spectroscopy (LIBS) as a tool for quantitative assessment of fuel retention in the first walls. One open problem related to LIBS application is the choice of the laser type. Here we compare two Nd/YAG lasers with different pulse durations, 0.15 and 8 ns, working at λ = 1064 nm for LIBS studies of samples with D-doped W/Al coatings of ≈ 3 μm thickness (Al is used as a proxy of Be) on Mo. Low pressure argon was used as a background gas. Experiments were done in conditions where other factors (broadening of spectral lines, signal-to-noise ratio, limited thickness of coatings etc.) did not shadow the effect of laser pulse duration. For these reasons, low pressure argon was used as the background gas and fluences were kept at comparatively low values. Spectra of laser-produced plasma were recorded as a function of the number of laser pulses. Partially overlapping lines of hydrogen isotopes were fitted with Voigt contours, intensities were fitted and depth profiles of deuterium were reconstructed. The relative standard error of curve-fitting of spectra recorded with the laser of shorter pulse duration was two times smaller than that recorded by the longer pulse laser. The electron density was found from the Stark broadening of Hα line of the laser-produced plasma and the electron temperature of plasma was found on the basis W and Mo lines. It was found that in the case of ps laser an acceptable accuracy of the detection of deuterium was possible at considerably lower values of fluence. Steps needed for comparison of ps and ns lasers in ITER-relevant conditions were discussed.Horizon 2020 Framework Programme 633053; Institute of Solid State Physics, University of Latvia as the Center of Excellence has received funding from the European Union’s Horizon 2020 Framework Programme H2020-WIDESPREAD-01-2016-2017-TeamingPhase2 under grant agreement No. 739508, project CAMART